Bread and Circuses: Who’s Behind the Oxford Vaccine for COVID-19? – Architects for Social Housing (ASH)
https://architectsforsocialhousing.co.uk/2020/11/25/bread-and-circuses-whos-behind-the-oxford-vaccine-for-covid-19/amp/?__twitter_impression=true
https://architectsforsocialhousing.co.uk/2020/11/25/bread-and-circuses-whos-behind-the-oxford-vaccine-for-covid-19/amp/?__twitter_impression=true
Architects for Social Housing (ASH)
Bread and Circuses: Who’s Behind the Oxford Vaccine for COVID-19?
‘Give them bread and circuses and they will never revolt.’ — Juvenal
Over the past week the race for a vaccine for COVID-19 has approached the finishing line, with the Oxford Vaccine Group looking to be the first to cross in the UK. This has occasioned…
Over the past week the race for a vaccine for COVID-19 has approached the finishing line, with the Oxford Vaccine Group looking to be the first to cross in the UK. This has occasioned…
"Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA can inactivate tumor-suppressing proteins and thereby promote cancer."
In a Twist, Scientists Find Cancer Drivers Hiding in RNA, Not DNA | Memorial Sloan Kettering Cancer Center
https://www.mskcc.org/news/scientists-find-cancer-drivers-hiding-rna-not-dna?amp&__twitter_impression=true
In a Twist, Scientists Find Cancer Drivers Hiding in RNA, Not DNA | Memorial Sloan Kettering Cancer Center
https://www.mskcc.org/news/scientists-find-cancer-drivers-hiding-rna-not-dna?amp&__twitter_impression=true
Memorial Sloan Kettering Cancer Center
Scientists Find Cancer Drivers Hiding in a New Place
New findings from researchers at the Sloan Kettering Institute suggest that cancer causes may be lurking in the molecule that bridges DNA and protein.
ADENOVIRUSES ARE USED IN ASTRAZENECA-OXFORD AND SPUTNIK V.
Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver
"Intravenous (i.v.) delivery of recombinant adenovirus serotype 5 (Ad5) vectors for gene therapy is hindered by safety and efficacy problems. We have discovered a new pathway involved in unspecific Ad5 sequestration and degradation. After i.v. administration, Ad5 rapidly binds to circulating platelets, which causes their activation/aggregation and subsequent entrapment in liver sinusoids. Virus-platelet aggregates are taken up by Kupffer cells and degraded. Ad sequestration in organs can be reduced by platelet depletion prior to vector injection. Identification of this new sequestration mechanism and construction of vectors that avoid it could improve levels of target cell transduction at lower vector doses."
https://pubmed.ncbi.nlm.nih.gov/17301138/
Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver
"Intravenous (i.v.) delivery of recombinant adenovirus serotype 5 (Ad5) vectors for gene therapy is hindered by safety and efficacy problems. We have discovered a new pathway involved in unspecific Ad5 sequestration and degradation. After i.v. administration, Ad5 rapidly binds to circulating platelets, which causes their activation/aggregation and subsequent entrapment in liver sinusoids. Virus-platelet aggregates are taken up by Kupffer cells and degraded. Ad sequestration in organs can be reduced by platelet depletion prior to vector injection. Identification of this new sequestration mechanism and construction of vectors that avoid it could improve levels of target cell transduction at lower vector doses."
https://pubmed.ncbi.nlm.nih.gov/17301138/
PubMed
Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver - PubMed
Intravenous (i.v.) delivery of recombinant adenovirus serotype 5 (Ad5) vectors for gene therapy is hindered by safety and efficacy problems. We have discovered a new pathway involved in unspecific Ad5 sequestration and degradation. After i.v. administration…
Aaron Walton is welcome on this channel. https://twitter.com/Haydeano1/status/1371496568671588356?s=19
Twitter
Haydeano
https://t.co/As7GLrqoUI
Forwarded from Mike Yeadon
https://www.pei.de/EN/newsroom/hp-news/2021/210315-pei-informs-temporary-suspension-vaccination-astra-zeneca.html
...Compared to the status on 11 March 2021, additional cases (as of Monday, 15 March 2021) have now been reported in Germany. Analysing the new data status, the experts of the Paul-Ehrlich-Institut now see a striking accumulation of a special form of very rare cerebral vein thrombosis (sinus vein thrombosis) in connection with a deficiency of blood platelets (thrombocytopenia) and bleeding in temporal proximity to vaccinations with the COVID-19 vaccine AstraZeneca.
...Compared to the status on 11 March 2021, additional cases (as of Monday, 15 March 2021) have now been reported in Germany. Analysing the new data status, the experts of the Paul-Ehrlich-Institut now see a striking accumulation of a special form of very rare cerebral vein thrombosis (sinus vein thrombosis) in connection with a deficiency of blood platelets (thrombocytopenia) and bleeding in temporal proximity to vaccinations with the COVID-19 vaccine AstraZeneca.
www.pei.de
News - The Paul-Ehrlich-Institut informs - Temporary Suspension of Vaccination with COVID-19 Vaccine AstraZeneca
After intensive consultations on the serious thrombotic events that have occurred in Germany and Europe, the Paul-Ehrlich-Institut recommends the temporary suspension of vaccinations with the COVID-19 vaccine AstraZeneca.
Forwarded from Mike Yeadon
Thank you, Robin!
As usual, our complicit media do not trouble their audiences with anything useful.
My sincere hope is that the emerging reality - which I and others warned about last year - that there’s no such thing as a zero unwanted effect medical treatment, will prompt leaders to re-evaluate their cavalier approach to vaccination.
Those under 60 & in good health are not at elevated risk from this virus. It makes no sense from a medical ethics standpoint even to offer or encourage this majority group to accept an experimental intervention.
Especially when it’s unclear who gets the live round in the Russian roulette gamble.
This alone must kill stone dead the malign idiocy that is vaccine passports.
Best wishes,
Mike
As usual, our complicit media do not trouble their audiences with anything useful.
My sincere hope is that the emerging reality - which I and others warned about last year - that there’s no such thing as a zero unwanted effect medical treatment, will prompt leaders to re-evaluate their cavalier approach to vaccination.
Those under 60 & in good health are not at elevated risk from this virus. It makes no sense from a medical ethics standpoint even to offer or encourage this majority group to accept an experimental intervention.
Especially when it’s unclear who gets the live round in the Russian roulette gamble.
This alone must kill stone dead the malign idiocy that is vaccine passports.
Best wishes,
Mike
The Curious Case of Geert Vanden Bossche - Rosemary Frei
Vanden Bossche bases his views on unproven hypotheses. This is similar to, and builds on, high-profile modeling-paper authors who use theoretical frameworks to inflame fears about the supposed dangerousness of the new variants.
Despite this, Vanden Bossche’s views were very quickly and positively received by high-profile vaccine sceptics such as Dell Bigtree in his March 11 episode (starting at 57:25) and Vernon Coleman in his March 13 video and article.
But from my experience as a former long-time medical writer and journalist (1988-2016) — particularly a four-month stint with media-relations giant FleishmanHillard in 1994 (yes, I’ve worked for the dark side) — this has all the hallmarks of a drug-company astroturf campaign. It’s another step in the decades-long erasure of the fact that our sophisticated and highly effective immune systems work well and don’t need any assistance from the biomedical/pharmaceutical industry.
There’s abundant evidence that Vanden Bossche has a not-so-hidden agenda. For example, just before the three-minute mark in the video interview of Vanden Bossche by McMillan, Vanden Bossche indicates he’s a long-time vaccine developer. He adds he’s now is focusing on vaccines that “educate the immune system in ways that are to some extent more efficient than we do right now with our conventional vaccines.” Clearly he’s got significant conflicts of interest. Therefore he has zero credibility when it comes to advising the public about how to avoid negative effects of mass vaccination.
https://www.rosemaryfrei.ca/the-curious-case-of-geert-vanden-bossche/
Vanden Bossche bases his views on unproven hypotheses. This is similar to, and builds on, high-profile modeling-paper authors who use theoretical frameworks to inflame fears about the supposed dangerousness of the new variants.
Despite this, Vanden Bossche’s views were very quickly and positively received by high-profile vaccine sceptics such as Dell Bigtree in his March 11 episode (starting at 57:25) and Vernon Coleman in his March 13 video and article.
But from my experience as a former long-time medical writer and journalist (1988-2016) — particularly a four-month stint with media-relations giant FleishmanHillard in 1994 (yes, I’ve worked for the dark side) — this has all the hallmarks of a drug-company astroturf campaign. It’s another step in the decades-long erasure of the fact that our sophisticated and highly effective immune systems work well and don’t need any assistance from the biomedical/pharmaceutical industry.
There’s abundant evidence that Vanden Bossche has a not-so-hidden agenda. For example, just before the three-minute mark in the video interview of Vanden Bossche by McMillan, Vanden Bossche indicates he’s a long-time vaccine developer. He adds he’s now is focusing on vaccines that “educate the immune system in ways that are to some extent more efficient than we do right now with our conventional vaccines.” Clearly he’s got significant conflicts of interest. Therefore he has zero credibility when it comes to advising the public about how to avoid negative effects of mass vaccination.
https://www.rosemaryfrei.ca/the-curious-case-of-geert-vanden-bossche/
Rosemary Frei
The Curious Case of Geert Vanden Bossche
The Curious Case of Geert Vanden BosscheHis Open Letter, Video Interview and High-Profile SupportersRosemary Frei, MScMarch 16, 2021On March 6, an open letter by G
The best vaccines are the killer T-cells of our immune system. To activate they need vitamin D: in the blood. The amount of active vitamin D depends on sunshine exposure & nutrition or supplementation, plus a varied bacterial flora in the digestion system, & general wellbeing, good sleep, rest, and regular physical activity.
Therapeutic efficacy of macrolides in management of patients with mild COVID-19
Alaa Rashad, Asmaa Nafady, Mohammed H. Hassan, Haggagy Mansour, Usama Taya, Shamardan Ezzeldin S. Bazeed, Zaki F. Aref, Mennatallah Ali Abdelrahman Sayed, Hanaa Nafady-Hego, Aida A. Abdelmaksoud
The overall results revealed significant early improvement of symptoms (fever, dyspnea and cough) in patients treated with either azithromycin or clarithromycin compared to control group, also there was significant early conversion of SARS-CoV-2 PCR to negative in patients treated with either azithromycin or clarithromycin compared to control group (p˂0.05 for all).There was no significant difference in time to improvement of fever, cough, dyspnea, anosmia, GIT symptoms and time to PCR negative conversion between patients treated with azithromycin compared to patients treated with clarithromycin (p˃0.05 for all). Follow up chest CT done after 2 weeks of start of treatment showed significant improvement in patients treated with either azithromycin or clarithromycin compared to control group (p˂0.05 for all).Adding Clarithromycin or Azithromycin to the therapeutic protocols for COVID-19 could be beneficial for early control of fever and early PCR negative conversion in Mild COVID-19"
https://www.researchsquare.com/article/rs-181996/v1
Alaa Rashad, Asmaa Nafady, Mohammed H. Hassan, Haggagy Mansour, Usama Taya, Shamardan Ezzeldin S. Bazeed, Zaki F. Aref, Mennatallah Ali Abdelrahman Sayed, Hanaa Nafady-Hego, Aida A. Abdelmaksoud
The overall results revealed significant early improvement of symptoms (fever, dyspnea and cough) in patients treated with either azithromycin or clarithromycin compared to control group, also there was significant early conversion of SARS-CoV-2 PCR to negative in patients treated with either azithromycin or clarithromycin compared to control group (p˂0.05 for all).There was no significant difference in time to improvement of fever, cough, dyspnea, anosmia, GIT symptoms and time to PCR negative conversion between patients treated with azithromycin compared to patients treated with clarithromycin (p˃0.05 for all). Follow up chest CT done after 2 weeks of start of treatment showed significant improvement in patients treated with either azithromycin or clarithromycin compared to control group (p˂0.05 for all).Adding Clarithromycin or Azithromycin to the therapeutic protocols for COVID-19 could be beneficial for early control of fever and early PCR negative conversion in Mild COVID-19"
https://www.researchsquare.com/article/rs-181996/v1
Researchsquare
Therapeutic efficacy of macrolides in management of patients with mild COVID-19
Evidence on the efficacy of adding macrolides (azithromycin or clarithromycin) to the treatment regimen for COVID-19 is limited. We testify whether adding azithromycin or clarithromycin to a standard of care regimen was superior to standard of supportive…
It's Dr Simon's @simoneke birthday today. This is his immune boost protocol: t.me/goddek
Vitamin D deficiency is associated with compromised inflammatory responses and higher pulmonary involvement in COVID-19 affected patients, according to a study published in Respiratory Research. https://t.co/l0l9eDn9HT
Respiratory Research
Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients - Respiratory Research
Background Several immune mechanisms activate in COVID-19 pathogenesis. Usually, coronavirus infection is characterized by dysregulated host immune responses, interleukine-6 increase, hyper-activation of cytotoxic CD8 T lymphocytes. Interestingly, Vitamin…
PROBIOTICS & VIT D: "The vitamin D receptor is highly expressed in the gastrointestinal tract where it transacts gene expression..These results support the underlying hypothesis that the human gut microbiome and vitamin D metabolism are integrally related"
https://t.co/15rVFa1fkk
https://t.co/15rVFa1fkk
Nature
Vitamin D metabolites and the gut microbiome in older men
Nature Communications - Here, the authors investigate associations of vitamin D metabolites with gut microbiome in a cross-sectional analysis of 567 elderly men enrolled in the Osteoporotic...
Boris insists AstraZeneca jab is safe as more countries suspend it – but does the data support this claim? – The Daily Expose
"even though 1 million more doses of the Pfizer have been administered it fares much better in the number of adverse reactions reported compared to the Oxford jab.
The Pfizer jab has so far had 94,809 suspected adverse reactions, whereas the Oxford jab has had more than double this amount, now standing at a total of 201,622 suspected adverse reactions as of the 28th February 2021.
In the first report, which included adverse reactions reported to the MHRA Yellow Card Scheme up to the 24th January 2021, the rate of adverse reactions stood at 1 in every 333 people. Just a couple of weeks later this had increased to 1 in every 250. This rate has now increased to 1 in every 166 people, meaning the rate of adverse reactions has doubled in just one month."
https://dailyexpose.co.uk/2021/03/15/boris-insists-astrazeneca-jab-is-safe-as-more-countries-suspend-it-but-does-the-data-support-this-claim/
"even though 1 million more doses of the Pfizer have been administered it fares much better in the number of adverse reactions reported compared to the Oxford jab.
The Pfizer jab has so far had 94,809 suspected adverse reactions, whereas the Oxford jab has had more than double this amount, now standing at a total of 201,622 suspected adverse reactions as of the 28th February 2021.
In the first report, which included adverse reactions reported to the MHRA Yellow Card Scheme up to the 24th January 2021, the rate of adverse reactions stood at 1 in every 333 people. Just a couple of weeks later this had increased to 1 in every 250. This rate has now increased to 1 in every 166 people, meaning the rate of adverse reactions has doubled in just one month."
https://dailyexpose.co.uk/2021/03/15/boris-insists-astrazeneca-jab-is-safe-as-more-countries-suspend-it-but-does-the-data-support-this-claim/
The Expose
Boris insists AstraZeneca jab is safe as more countries suspend it - but does the data support this claim?
The Netherlands and Germany have joined the growing list of countries that have now suspended the use of the Oxford / Astrazeneca vaccine due to fears over it c
Vaccine Nationalism is a particularly virulent contemporary form & mutated variant of 1930s Nationalism. The National Vaccinist Party, also known as the #Vazis.